Oscar Health's share price on the New York Stock Exchange hovered around $31 Friday afternoon before market close, a decline of about 20% from the $39 pricing the company set for its initial public offering Tuesday evening.
Blue Cross and Blue Shield of Minnesota sued now-incarcerated Martin "Pharma Bro" Shkreli, alleging the company intentionally monopolized the market and illegally jacked up the price of a "gold-standard" drug.
Alignment Healthcare, an Orange, Calif.-based startup that offers Medicare Advantage plans, is preparing to go public. It estimates the Medicare Advantage market will be worth $500 billion by 2025.
Before the pandemic, a majority of U.S. healthcare industry leaders—including nearly half of the nation’s hospital boards—said their organization did not have a formal succession plan in place.
Modern Healthcare’s "Next Up" podcast is produced by CareContent, Inc. and hosted by CareContent’s CEO, Kadesha Thomas Smith.